Detection of human parvovirus b19 infection in first‐trimester fetal loss

Obstetrics and Gynecology

Volumn 99, Issue 5, 2002, Pages 795-798

  Nyman, Margareta ^a   Tolfvenstam, Thomas ^a   Petersson, Karin ^a   Krassny, Christina ^b   Skjöldebrand‐Sparre, Lottie ^b   Broliden, Kristina ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CONTROLLED STUDY; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; MATERNAL SERUM; PARVOVIRUS; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SWEDEN; VIRUS DETECTION;

ABORTION, SPONTANEOUS; ADULT; DNA, VIRAL; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MATERNAL AGE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES;

EID: 0036224978     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200205000-00020     Document Type: Article

References (25)

1. Anderson LJ, Young NS, eds. Monographs in virology: Human parvovirus B19. Vol. 20. Basel, Switzerland: Karger; 1997.
2. Knott PD, Welply GA, Anderson MJ. Serologically proved intrauterine infection with parvovirus. Br Med J Clin Res 1984;289:1660.
3. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in human fetus. Br J Obstet Gynaecol 1992;99:566-74.
4. Levi R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B19 during pregnancy: A review. Obstet Gynecol Survey 1997;52:254-9.
5. Petrikovsky BM, Baker D, Schneider E. Fetal hydrops secondary to human parvovirus infection in early pregnancy. Prenat Diagn 1996;16:342-4.
6. Brandenburg H, Los FJ, Cohen-Overbeek TE. A case of early intrauterine parvovirus B19 infection. Prenat Diagn 1996;16:75-7.
7. de Krijger RR, van Elsacker-Niele AMW, Mulder-Stapel A, Salimans MM, Dreef E, Weiland MT, et al. Detection of parvovirus B19 infection in first and second trimester fetal loss. Ped Pathol Lab Med 1998;18:23-34.
8. Rogers BB, Singer DB, Mak SK, Gary GW, Fikrig MK, McMillan PN. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, and the polymerase chain reaction. Obstet Gynecol 1993;81:402-8.
9. Sifakis S, Ergazaki M, Sourvinos G, Koffa M, Koumantakis E, Spandidos DA. Evaluation of Parvo B19, CMV and HPV viruses in human aborted material using the polymerase chain reaction technique. Eur J Obstet Gynecol Reprod Biol 1998;76:169-73.
10. Skjöldenbrand-Sparre L, Tolfvenstam T, Papadogiannakis N, Wahren B, Broliden K, Nyman M. Parvovirus B19 infection: Association with third-trimester intrauterine fetal death. Br J Obstet Gynaecol 2000;107:476-80.
11. Skjöldebrand-Sparre L, Nyman M, Broliden K, Wahren B. All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid. Am J Obstet Gynecol 1999;180:1595-6.
12. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Human parvovirus B19 in intrauterine fetal death. Lancet 2001;357:1494-7.
13. Lundqvist A, Tolfvenstam T, Brytting M, Stolt CM, Hedman K, Broliden K. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders. Scand J Infect Dis 1999;31:119-22.
14. Koch WC, Harger JH, Barnstein B, Adler SP. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 1998;17:489-94.
15. Lowden E, Weinstein L. Unexpected second trimester pregnancy loss due to maternal parvovirus B19 infection. Southern Med J 1997;90:702-4.
16. Jordan JA. Identification of human parvovirus B19 in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996;174:37-42.
17. Gratacos E, Torres PJ, Vidal J, Antolin E, Costa J, Jimenez de Anta MT, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171:1360-3.
18. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105:174-8.
19. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirrus B19: Risks and symptoms. Obstet Gynecol 1998;91:413-20.
20. Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, et al. Possible interactions between the NS-1 protein and tumor necrosis factor in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999;73:8762-70.
21. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993;262:114-7.
22. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988;i:535-6.
23. Saint-Martin J, Choulot JJ, Bonnaud E, Morinet F. Myocarditis caused by parvovirus. J Pediatr 1990;116:1007-8.
24. Barton LL, Lax D, Shehab ZM, Keith JC. Congenital cardiomyopathy associated with human parvovirus B19 infection. Am Heart J 1997;133:131-3.
25. Finkel TH, Török TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or etiological agent? Lancet 1994;343:1255-8.